loader
Please Wait
Applying Filters...

Inabata Inabata

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Firsocostat, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Firsocostat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    SPI Pharma has been solving formulation challenges using superior functional materials.

    2D Structure
    1. Also known as: Nd-630, 1434635-54-7, Gs-acc, Ndi-010976, Gs-0976, Firsocostat [usan]
    Molecular Formula
    C28H31N3O8S
    Molecular Weight
    569.6  g/mol
    InChI Key
    ZZWWXIBKLBMSCS-FQEVSTJZSA-N
    FDA UNII
    XE10NJQ95M
    Firsocostat is under investigation in clinical trial NCT02781584 (Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid
    2.1.2 InChI
    InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1
    2.1.3 InChI Key
    ZZWWXIBKLBMSCS-FQEVSTJZSA-N
    2.1.4 Canonical SMILES
    CC1=C(SC2=C1C(=O)N(C(=O)N2CC(C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5
    2.1.5 Isomeric SMILES
    CC1=C(SC2=C1C(=O)N(C(=O)N2C[C@@H](C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5
    2.2 Other Identifiers
    2.2.1 UNII
    XE10NJQ95M
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-(1-((2r)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic Acid

    2. Gs-0976

    2.3.2 Depositor-Supplied Synonyms

    1. Nd-630

    2. 1434635-54-7

    3. Gs-acc

    4. Ndi-010976

    5. Gs-0976

    6. Firsocostat [usan]

    7. Xe10njq95m

    8. 2-[1-[(2r)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic Acid

    9. (r)-2-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2h-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2h)-yl)-2-methylpropanoic Acid

    10. 2-(1-((2r)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic Acid

    11. Firsocostat [inn]

    12. Firsocostat (usan/inn)

    13. Unii-xe10njq95m

    14. Firsocostat (gs-0976)

    15. Firsocostat [who-dd]

    16. Schembl14945041

    17. Gtpl10645

    18. Amy16826

    19. Ex-a2586

    20. Firsocostat(nd-630,gs-0976)

    21. Nd 630;nd630

    22. S8893

    23. Who 10738

    24. Akos037648731

    25. Zinc207531097

    26. Cs-6509

    27. Ac-31460

    28. Bs-15388

    29. Hy-16901

    30. Nd-630; Ndi-010976; Firsocostat

    31. D11640

    32. 1,4-dihydro-1-((2r)-2-(2-methoxyphenyl)-2-((tetrahydro-2h-pyran-4-yl)oxy)ethyl)-.alpha.,.alpha.,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno(2,3-d)pyrimidine-3(2h)-acetic Acid

    33. 1,4-dihydro-1-((2r)-2-(2-methoxyphenyl)-2-((tetrahydro-2h-pyran-4-yl)oxy)ethyl)-alpha,alpha,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno(2,3-d)pyrimidine-3(2h)-acetic Acid

    34. 2-[1-[(r)-beta-[(tetrahydro-2h-pyran-4-yl)oxy]-2-methoxyphenethyl]-2,4-dioxo-5-methyl-6-(oxazole-2-yl)-1,2-dihydrothieno[2,3-d]pyrimidine-3(4h)-yl]-2-methylpropanoic Acid

    35. Thieno(2,3-d)pyrimidine-3(2h)-acetic Acid, 1,4-dihydro-1-((2r)-2-(2-methoxyphenyl)-2-((tetrahydro-2h-pyran-4-yl)oxy)ethyl)-.alpha.,.alpha.,5-trimethyl-6-(2-oxazolyl)-2,4-dioxo-

    2.4 Create Date
    2013-06-11
    3 Chemical and Physical Properties
    Molecular Weight 569.6 g/mol
    Molecular Formula C28H31N3O8S
    XLogP33.2
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count9
    Exact Mass569.18318613 g/mol
    Monoisotopic Mass569.18318613 g/mol
    Topological Polar Surface Area160 Ų
    Heavy Atom Count40
    Formal Charge0
    Complexity947
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    Post Enquiry
    POST ENQUIRY